male balance
NDC 69779-008, Centarium umbellatum, flos, Ceratostigma willmottianum, flos, Kali Phos, Larix decidua, flos, Lycopodium, Nat Mur, Nat Phos, Silicea, spray, from Siddha Flower Essences LLC.
- Product NDC
- 69779-008
- Status
- Listed
- Labeler
- Siddha Flower Essences LLC
- Dosage form
- SPRAY
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69779-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CENTAURIUM ERYTHRAEA FLOWER5 [hp_X]/29.6mL
- CERATOSTIGMA WILLMOTTIANUM FLOWER5 [hp_X]/29.6mL
- POTASSIUM PHOSPHATE, DIBASIC6 [hp_X]/29.6mL
- LARIX DECIDUA FLOWERING TOP5 [hp_X]/29.6mL
- LYCOPODIUM CLAVATUM SPORE6 [hp_C]/29.6mL
- SODIUM CHLORIDE6 [hp_X]/29.6mL
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE6 [hp_X]/29.6mL
- SILICON DIOXIDE12 [hp_X]/29.6mL
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69779-008-01 | 69779000801 | 1 BOTTLE in 1 CARTON (69779-008-01) / 29.6 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 69779-008 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69779-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69779-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.